$BKKT

D'Annunzio Marc sold $23K of BKKT

D'Annunzio Marc (General Counsel & Secretary) sold 2,919 shares of Bakkt, Inc. (BKKT) at an average of $7.83 ($7.71–$7.93) across 2 trades over 2026-06-25 to 2026-06-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · D'Annunzio Marc
Published Jun 29, 2026, 10:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BKKT
Neutral
medium confidence
Mentioned
$BKKT
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKKTNeutralLow
01

Why it matters

The newest fact is the specific open-market sale by the company’s General Counsel/Secretary (2,919 shares; ~$22.8k total) executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a fresh, timestamped insider-selling datapoint, but it is small and pre-arranged, so it is unlikely to drive a durable repricing.

03

What to watch

Traders may over-weight small insider sales; without accompanying changes in guidance, contracts, or financing, the signal is usually weak.

Relevance 2/10Novelty 2/10Timing: filed after-hours on 2026-06-29; reflects trades dated 2026-06-25 to 2026-06-26

Background

The article is an SEC Form 4 insider transaction disclosure for Bakkt, Inc. (BKKT).

Company-level read

Ticker impact

$BKKTNeutralMedium confidence
Context

SEC Form 4 shows Bakkt’s General Counsel sold 2,919 shares in open-market trades under a 10b5-1 plan at ~$7.71–$7.93.

Expected impact

Near-term impact likely minimal; any reaction would be more sentiment/flow-driven than fundamental.

Evidence & confidence

The filing is a pre-arranged 10b5-1 plan and the transaction size (~$22.8k) is small, reducing expected price sensitivity.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because it’s a 10b5-1 plan, the sale may be purely scheduled liquidity rather than a bearish view on Bakkt’s prospects.

Key entities

  • Bakkt, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • D'Annunzio Marc

    General Counsel & Secretary who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKKTMedAI 8/10

Bakkt (BKKT) Q2 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q2 2026 revenue of $170.1 million, down 70% from $568.1 million, citing client transitions and weaker digital asset trading volumes. GAAP net income was $80.8 million, driven mainly by a $98.5 million non-cash gain from Transchem warrants. Total transacting volume was $168.8 million; management reiterated an EBITDA breakeven target in Q4 2026.

$BKKTMed

Bakkt Inc (BKKT) (Q2 2026) Earnings Call Highlights: Strong GAAP Net Income

Bakkt’s CEO Akshay Naheta said the company expects adjusted EBITDA break-even in Q4 2026, without a specific date, citing execution and client activations. Management discussed take rates, cross-border margins, and reaffirmed a 2026 TTV target of about $2.5 billion. The firm outlined post-DTR acquisition progress and Bakkt Agent MAU target of ~25,000 by year-end 2026.

$BKKTMed

Bakkt, Inc. (BKKT): Results of Operations and Financial Condition

Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live across Bakkt Markets; Total Transacting Volume (“TTV”) of $168.8 million in Q2, including payments volume generated on acqu